# Efficacy Study Of Tofacitinib In Pediatric JIA Population

> **NCT02592434** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 225 (actual)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** CP-690,550 (tofacitinib)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02592434
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-10
- **Primary completion:** 2019-05-16
- **Final completion:** 2019-05-16
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592434, "Efficacy Study Of Tofacitinib In Pediatric JIA Population". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02592434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*